Advertisement

Neurological Emergencies in Pregnancy

  • Sucharita Ray
  • Rohit Bhatia
  • Mamta Bhushan Singh
Chapter

Abstract

Pregnancy in women is important for significant and marked physiological changes occurring to the body. Several disease conditions are known to have marked exacerbations as well as abetment during pregnancy owing to these changes occurring in the body. The pathophysiologic mechanisms for exacerbation can be secondary to pregnancy itself or may occur due to a completely unrelated mechanism. It is of extreme importance to understand the pathophysiologic mechanism and behavior of each of these disease conditions to ensure timely treatment and reduce morbidity and mortality of both mother and child. Here we focus on the neurological conditions with acute aggravations during pregnancy as well as primarily non-neurological conditions with a significant neurologic complication which may occur in pregnancy and discuss their modes of presentations, pathophysiologic basis, treatment, etc. The condition of cerebral venous thrombosis is dealt with in detail elsewhere in this book and hence will not be covered in this chapter.

References

  1. 1.
    Heidemann BH, McClure JH. Changes in maternal physiology during pregnancy. BJA CEPD Rev. 2003;3(3):65–8.CrossRefGoogle Scholar
  2. 2.
    Dreyfus M, Tissier I, Baldauf JJ, Ritter J. HELLP syndrome. Review and update. J Gynécol Obstét Biol Reprod. 1997;26(1):9–15.Google Scholar
  3. 3.
    Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth. 2009;9:8.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Paul BS, Juneja SK, Paul G, Gupta S. Spectrum of neurological complications in HELLP syndrome. Neurol India. 2013;61(5):467–71.PubMedCrossRefGoogle Scholar
  5. 5.
    Saphier CJ, Repke JT. Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a review of diagnosis and management. Semin Perinatol. 1998;22(2):118–33.PubMedCrossRefGoogle Scholar
  6. 6.
    Barton JR, Sibai BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol. 2004;31(4):807–33, vii.PubMedCrossRefGoogle Scholar
  7. 7.
    Demopoulos A, DeAngelis LM. Neurologic complications of leukemia. Curr Opin Neurol. 2002;15(6):691–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Chamberlain MC. Neurologic complications of leukemia. In: Schiff D, Kesari S, Wen PY, editors. Cancer neurology in clinical practice [Internet]. New York: Humana Press; 2008 [cited 2016 Aug 6]. p. 555–565. http://link.springer.com/chapter/10.1007/978-1-59745-412-4_29.
  9. 9.
    Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin. 2003;21(1):167–92.PubMedCrossRefGoogle Scholar
  10. 10.
    Mahmoud HK, Samra MA, Fathy GM. Hematologic malignancies during pregnancy: a review. J Adv Res. 2016;7(4):589–96.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Weisz B, Meirow D, Schiff E, Lishner M. Impact and treatment of cancer during pregnancy. Expert Rev Anticancer Ther. 2004;4(5):889–902.PubMedCrossRefGoogle Scholar
  12. 12.
    Pentheroudakis G, Orecchia R, Hoekstra HJ, Pavlidis N. Group O behalf of the EGW. Cancer, fertility and pregnancy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl 5):v266–73.PubMedCrossRefGoogle Scholar
  13. 13.
    Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy. Blood Rev. 2008;22(5):247–59.PubMedCrossRefGoogle Scholar
  14. 14.
    Iseminger KA, Lewis MA. Ethical challenges in treating mother and fetus when cancer complicates pregnancy. Obstet Gynecol Clin N Am. 1998;25(2):273–85.CrossRefGoogle Scholar
  15. 15.
    Southwick FS, Purich DL. Intracellular pathogenesis of listeriosis. N Engl J Med. 1996;334(12):770–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Janakiraman V. Listeriosis in pregnancy: diagnosis, treatment, and prevention. Rev Obstet Gynecol. 2008;1(4):179–85.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Abrahamian FM, Moran GJ, Talan DA. Community-acquired bacterial meningitis. N Engl J Med. 2006;354(13):1429–32.PubMedCrossRefGoogle Scholar
  18. 18.
    Landrum LM, Hawkins A, Goodman JR. Pneumococcal meningitis during pregnancy: a case report and review of literature. Infect Dis Obstet Gynecol [Internet]. 2007 [cited 2016 Aug 11]. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852901/.
  19. 19.
    Adriani KS, Brouwer MC, van der Ende A, van de Beek D. Bacterial meningitis in pregnancy: report of six cases and review of the literature. Clin Microbiol Infect. 2012;18(4):345–51.PubMedCrossRefGoogle Scholar
  20. 20.
    Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267–84.PubMedCrossRefGoogle Scholar
  21. 21.
    Costa MLB, Souza JP, Oliveira Neto AF, Pinto E Silva JL. Cryptococcal meningitis in HIV negative pregnant women: case report and review of literature. Rev Inst Med Trop Sao Paulo. 2009;51(5):289–94.PubMedCrossRefGoogle Scholar
  22. 22.
    Anzivino E, Fioriti D, Mischitelli M, Bellizzi A, Barucca V, Chiarini F, et al. Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention. Virol J. 2009;6:40.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Stommel EW, Seguin R, Thadani VM, Schwartzman JD, Gilbert K, Ryan KA, et al. Cryptogenic epilepsy: an infectious etiology? Epilepsia. 2001;42(3):436–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494–500.PubMedCrossRefGoogle Scholar
  25. 25.
    Tam CS, Galanos J, Seymour JF, Pitman AG, Stark RJ, Prince HM. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. Am J Hematol. 2004;77(1):72–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Long TR, Hein BD, Brown MJ, Rydberg CH, Wass CT. Posterior reversible encephalopathy syndrome during pregnancy: seizures in a previously healthy parturient. J Clin Anesth. 2007;19(2):145–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Swende TZ, Abwa T. Reversible blindness in fulminating preeclampsia. Ann Afr Med. 2009;8(3):189–91.PubMedGoogle Scholar
  28. 28.
    Postma IR, Slager S, Kremer HPH, de Groot JC, Zeeman GG. Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature. Obstet Gynecol Surv. 2014;69(5):287–300.PubMedCrossRefGoogle Scholar
  29. 29.
    Hobson EV, Craven I, Blank SC. Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness. Perit Dial Int. 2012;32(6):590–4.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;28(7):1320–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Fisher N, Saraf S, Egbert N, Homel P, Stein EG, Minkoff H. Clinical correlates of posterior reversible encephalopathy syndrome in pregnancy. J Clin Hypertens. 2016;18(6):522–7.CrossRefGoogle Scholar
  32. 32.
    Otani K. Risk factors for the increased seizure frequency during pregnancy and puerperium. Folia Psychiatr Neurol Jpn. 1985;39(1):33–41.PubMedGoogle Scholar
  33. 33.
    Schmidt D, Canger R, Avanzini G, Battino D, Cusi C, Beck-Mannagetta G, et al. Change of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiatry. 1983;46(8):751–5.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Lu Y-T, Hsu C-W, Tsai W-C, Cheng M-Y, Shih F-Y, Fu T-Y, et al. Status epilepticus associated with pregnancy: a cohort study. Epilepsy Behav. 2016;59:92–7.PubMedCrossRefGoogle Scholar
  35. 35.
    EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology. 2006;66(3):354–60.CrossRefGoogle Scholar
  36. 36.
    Di Bonaventura C, Mari F, Vanacore N, Fattouch J, Zarabla A, Berardelli A, et al. Status epilepticus in epileptic patients: related syndromes, precipitating factors, treatment and outcome in a video-EEG population-based study. Seizure. 2008;17(6):535–48.PubMedCrossRefGoogle Scholar
  37. 37.
    Elliott AB, Chakravarty EF. Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases. Womens Health (Lond). 2010;6(3):431–40.CrossRefGoogle Scholar
  38. 38.
    Tate J, Bushnell C. Pregnancy and stroke risk in women. Womens Health (Lond). 2011;7(3):363–74.CrossRefGoogle Scholar
  39. 39.
    Davie CA, O’Brien P. Stroke and pregnancy. J Neurol Neurosurg Psychiatry. 2008;79(3):240–5.PubMedCrossRefGoogle Scholar
  40. 40.
    James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol. 2005;106(3):509–16.PubMedCrossRefGoogle Scholar
  41. 41.
    Bateman BT, Olbrecht VA, Berman MF, Minehart RD, Schwamm LH, Leffert LR. Peripartum subarachnoid hemorrhage: nationwide data and institutional experience. Anesthesiology. 2012;116(2):324–33.PubMedCrossRefGoogle Scholar
  42. 42.
    Bateman BT, Schumacher HC, Bushnell CD, Pile-Spellman J, Simpson LL, Sacco RL, et al. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology. 2006;67(3):424–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Lin L-T, Tsui K-H, Cheng J-T, Cheng J-S, Huang W-C, Liou W-S, et al. Increased risk of intracranial hemorrhage in patients with pregnancy-induced hypertension: a nationwide population-based retrospective cohort study. Medicine (Baltimore). 2016;95(20):e3732.CrossRefGoogle Scholar
  44. 44.
    Saposnik G, Barinagarrementeria F, Brown RD, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158–92.PubMedCrossRefGoogle Scholar
  45. 45.
    Lath R, Kumar S, Reddy R, Boola GR, Ray A, Prabhakar S, et al. Decompressive surgery for severe cerebral venous sinus thrombosis. Neurol India. 2010;58(3):392–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Guida M, Altieri R, Palatucci V, Visconti F, Pascale R, Marra M, et al. Aneurysmal subarachnoid haemorrhage in pregnancy: a case series. Transl Med UniSa. 2012;18(2):59–63.Google Scholar
  47. 47.
    Fox MW, Harms RW, Davis DH. Selected neurologic complications of pregnancy. Mayo Clin Proc. 1990;65(12):1595–618.PubMedCrossRefGoogle Scholar
  48. 48.
    Gaist D, Pedersen L, Cnattingius S, Sørensen HT. Parity and risk of subarachnoid hemorrhage in women: a nested case-control study based on national Swedish registries. Stroke J Cereb Circ. 2004;35(1):28–32.CrossRefGoogle Scholar
  49. 49.
    Brisman MH, Bederson JB. Surgical management of subarachnoid hemorrhage. New Horiz. 1997;5(4):376–86.PubMedGoogle Scholar
  50. 50.
    Tremblay E, Thérasse E, Thomassin-Naggara I, Trop I. Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation. Radiographics. 2012;32(3):897–911.PubMedCrossRefGoogle Scholar
  51. 51.
  52. 52.
    Ginsberg JS, Kowalchuk GG, Hirsh JJ, Brill-Edwards PP, Burrows RR. Heparin therapy during pregnancy: risks to the fetus and mother. Arch Intern Med. 1989;149(10):2233–6.PubMedCrossRefGoogle Scholar
  53. 53.
    Johnson DM, Kramer DC, Cohen E, Rochon M, Rosner M, Weinberger J. Thrombolytic therapy for acute stroke in late pregnancy with intra-arterial recombinant tissue plasminogen activator. Stroke J Cereb Circ. 2005;36(6):e53–5.CrossRefGoogle Scholar
  54. 54.
    Gartman EJ. The use of thrombolytic therapy in pregnancy. Obstet Med. 2013;6(3):105–11.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    De Keyser J, Gdovinová Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ. Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke. 2007;38(9):2612–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Aaron S, Shyamkumar NK, Alexander S, Babu PS, Prabhakar AT, Moses V, et al. Mechanical thrombectomy for acute ischemic stroke in pregnancy using the penumbra system. Ann Indian Acad Neurol. 2016;19(2):261–3.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Bhogal P, Aguilar M, AlMatter M, Karck U, Bäzner H, Henkes H. Mechanical thrombectomy in pregnancy: report of 2 cases and review of the literature. Interv Neurol. 2017;6(1–2):49–56.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Grear KE, Bushnell CD. Stroke and pregnancy: clinical presentation, evaluation, treatment and epidemiology. Clin Obstet Gynecol. 2013;56(2):350–9.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Kittner SJ, Stern BJ, Feeser BR, Hebel R, Nagey DA, Buchholz DW, et al. Pregnancy and the risk of stroke. N Engl J Med. 1996;335(11):768–74.PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Richards A, Graham D, Bullock R. Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy. J Neurol Neurosurg Psychiatry. 1988;51(3):416–21.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Zeeman GG. Neurologic complications of pre-eclampsia. Semin Perinatol. 2009;33(3):166–72.PubMedCrossRefGoogle Scholar

Copyright information

© The Author(s) 2019

Authors and Affiliations

  • Sucharita Ray
    • 1
  • Rohit Bhatia
    • 1
  • Mamta Bhushan Singh
    • 1
  1. 1.Department of NeurologyPostgraduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations